lilly direct semaglutide Exciting Zepbound News! 🎉 has expanded their options with new vial doses and pricing, making weight loss medication more accessible. Get the details: * Affordable vial options now available through Lilly Lilly's KwikPen Delivers Month of

Within three months on the protocol Dr

What stood out: CagriSema achieved 23.0% weight loss at 84 weeks (efficacy estimand) Tirzepatide achieved 25.5% On the treatment-regimen estimand, weight loss was 20.2% vs 23.6% Primary endpoint not met: CagriSema did not demonstrate non-inferiority vs tirzepatide on weight loss at 84 weeks Why this matters This is a reminder that in obesity pharmacotherapy, very effective and best-in-class are not the same conversation

Whatever helps you chill, meditation, journaling, knitting cat sweaters, do more of that

By combining a triple agonist peptide with a specialised recovery peptide blend, this bundle supports broader research into receptor interaction, tissue-repair pathways, peptide pharmacology, and cellular response modelling under controlled laboratory conditions.